We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-14.46%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$80.1M
AUM Growth
-$50.5M
Cap. Flow
-$32.1M
Cap. Flow %
-40.06%
Top 10 Hldgs %
38.33%
Holding
132
New
21
Increased
24
Reduced
28
Closed
44

Top Buys

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$1.9M
2
GDDY icon
GoDaddy
GDDY
+$1.89M
3
BLK icon
Blackrock
BLK
+$1.79M
4
TMO icon
Thermo Fisher Scientific
TMO
+$1.19M
5
MSFT icon
Microsoft
MSFT
+$947K

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$2.54M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.36M
3
SPOT icon
Spotify
SPOT
+$1.91M
4
A icon
Agilent Technologies
A
+$1.72M
5
AAPL icon
Apple
AAPL
+$1.67M

Sector Composition

Rank Sector Weight
1 Healthcare 53.85%
2 Technology 19.35%
3 Financials 6.38%
4 Communication Services 4.09%
5 Consumer Discretionary 3.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
51
AnaptysBio
ANAB
$1.68B
$429K 0.54%
6,731
-5,092
-43% -$379K
CSII
52
DELISTED
Cardiovascular Systems, Inc.
CSII
$415K 0.52%
14,574
+3,407
+31% +$108K
TWLO icon
53
Twilio
TWLO
$36.6B
$343K 0.43%
+3,842
New +$312K
SLDB icon
54
Solid Biosciences
SLDB
$900M
$328K 0.41%
817
+377
+86% +$177K
ACOR
55
CALL
DELISTED
Acorda Therapeutics
ACOR
$326K 0.41%
174
– –
IRTC icon
56
iRhythm Holdings
IRTC
$4.2B
$325K 0.41%
4,681
+2,378
+103% +$180K
NVRO
57
DELISTED
NEVRO CORP.
NVRO
$267K 0.33%
+6,854
New +$305K
GDOT icon
58
Green Dot
GDOT
$745M
$265K 0.33%
+3,335
New +$263K
PCRX icon
59
Pacira BioSciences
PCRX
$997M
$265K 0.33%
6,151
-24,882
-80% -$1.16M
NOW icon
60
ServiceNow
NOW
$129B
$251K 0.31%
+7,055
New +$250K
RAMP icon
61
LiveRamp
RAMP
$2.3B
$223K 0.28%
5,763
-10,414
-64% -$472K
ACOR
62
DELISTED
Acorda Therapeutics
ACOR
$204K 0.25%
109
-20
-16% -$43.5K
GRTS
63
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$171K 0.21%
12,951
-141
-1% -$2.69K
FATE icon
64
Fate Therapeutics
FATE
$326M
$158K 0.2%
12,287
-100
-0.8% -$1.39K
KURA icon
65
Kura Oncology
KURA
$850M
$141K 0.18%
10,072
– –
ESTC icon
66
Elastic
ESTC
$7.81B
$137K 0.17%
+1,911
New +$129K
ALLO icon
67
Allogene Therapeutics
ALLO
$694M
$135K 0.17%
+5,007
New +$133K
VRAY
68
DELISTED
ViewRay, Inc.
VRAY
$131K 0.16%
21,604
+13,007
+151% +$97.5K
ARGX icon
69
argenx
ARGX
$54.1B
$110K 0.14%
+1,148
New +$102K
LYV icon
70
Live Nation Entertainment
LYV
$42.1B
$101K 0.13%
+2,053
New +$108K
CBLK
71
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$83K 0.1%
6,163
– –
ARAY icon
72
Accuray
ARAY
$34M
$76K 0.09%
22,424
-9,089
-29% -$36.9K
EQ icon
73
Equillium
EQ
$133M
$64K 0.08%
+7,879
New +$110K
ZS icon
74
Zscaler
ZS
$27.3B
$49K 0.06%
1,258
– –
STNE icon
75
StoneCo
STNE
$2.58B
$42K 0.05%
+2,289
New +$52.9K
1 2
3
4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Partner Investment Management held 132 positions worth $80.1M, down 39% from $131M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Partner Investment Management withdrew a net $32.1M in Q4 2018, closing 44 positions and reducing 28 holdings. Its most notable exit was Viatris, an estimated $2.54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

Against the trend, Partner Investment Management opened a new position in Microchip Technology worth $1.94M.

  • Partner Investment Management's largest Q4 2018 buy was Microchip Technology: 53,950 shares worth $1.94M.
  • Partner Investment Management added most to GoDaddy in Q4 2018, an estimated $1.89M increase.
  • Partner Investment Management's biggest Q4 2018 reduction was Pacira BioSciences, cutting an estimated $1.16M.
  • Partner Investment Management fully exited Viatris in Q4 2018, selling an estimated $2.54M.
  • Partner Investment Management's ten largest holdings make up 38% of its $80.1M portfolio in Q4 2018.
  • Partner Investment Management opened 21 new positions and closed 44 in Q4 2018.
  • Partner Investment Management's portfolio value fell 39% quarter-over-quarter to $80.1M.

Based on Partner Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.